全文获取类型
收费全文 | 970篇 |
免费 | 65篇 |
国内免费 | 2篇 |
专业分类
耳鼻咽喉 | 2篇 |
儿科学 | 16篇 |
妇产科学 | 13篇 |
基础医学 | 91篇 |
口腔科学 | 9篇 |
临床医学 | 87篇 |
内科学 | 157篇 |
皮肤病学 | 11篇 |
神经病学 | 272篇 |
特种医学 | 63篇 |
外科学 | 52篇 |
综合类 | 22篇 |
一般理论 | 1篇 |
预防医学 | 106篇 |
眼科学 | 7篇 |
药学 | 66篇 |
肿瘤学 | 62篇 |
出版年
2022年 | 8篇 |
2021年 | 24篇 |
2020年 | 11篇 |
2019年 | 13篇 |
2018年 | 24篇 |
2017年 | 21篇 |
2016年 | 15篇 |
2015年 | 23篇 |
2014年 | 33篇 |
2013年 | 30篇 |
2012年 | 47篇 |
2011年 | 29篇 |
2010年 | 26篇 |
2009年 | 28篇 |
2008年 | 37篇 |
2007年 | 33篇 |
2006年 | 40篇 |
2005年 | 58篇 |
2004年 | 42篇 |
2003年 | 36篇 |
2002年 | 28篇 |
2001年 | 31篇 |
2000年 | 27篇 |
1999年 | 30篇 |
1998年 | 11篇 |
1997年 | 14篇 |
1995年 | 15篇 |
1994年 | 11篇 |
1993年 | 14篇 |
1992年 | 17篇 |
1991年 | 20篇 |
1990年 | 13篇 |
1989年 | 16篇 |
1988年 | 8篇 |
1987年 | 21篇 |
1986年 | 9篇 |
1985年 | 6篇 |
1984年 | 9篇 |
1983年 | 6篇 |
1982年 | 11篇 |
1981年 | 7篇 |
1980年 | 10篇 |
1979年 | 15篇 |
1978年 | 21篇 |
1977年 | 11篇 |
1976年 | 11篇 |
1975年 | 12篇 |
1974年 | 12篇 |
1973年 | 9篇 |
1972年 | 6篇 |
排序方式: 共有1037条查询结果,搜索用时 15 毫秒
1.
Irritable bowel syndrome and health-related quality of life: a population-based study in Calgary, Alberta. 总被引:3,自引:0,他引:3
Feng Xiao Li Scott B Patten Robert J Hilsden Lloyd R Sutherland 《Journal canadien de gastroenterologie》2003,17(4):259-263
BACKGROUND: Little is known about the health-related quality of life (HRQOL) of nonclinical samples of people with irritable bowel syndrome (IBS) in Canada. In a pilot survey, the impact of IBS on HRQOL using a population-based, urban sample was examined. METHODS: A random sample of Calgary residents (18 years of age or older), selected by random digit dialing (n=1521), completed a structured questionnaire including ROME II Criteria and Medical Outcomes Study Short-Form 12-Item Health Survey, version 2 (SF-12v2). The mean scale and summary scores of SF-12v2 for those who did and did not meet ROME II criteria and for those who met ROME II criteria with and without visiting a physician in past three months were determined and compared using multiple regression analyses. RESULTS: Of the 951 households successfully contacted, 590 (62%) were willing to participate, of which 437 (74%) individuals were recruited. One hundred ten IBS cases (81 of which were women) and 327 non-IBS controls (180 of which were women) were identified. All of the eight mean scale scores and the two mean summary scores were significantly lower in people with IBS than in those without, whether or not adjusting for demographics. Forty-four of the 110 IBS cases (40%) sought medical help. Significantly lower mean physical component score and three scale scores (general health, social functioning and role physical) were found in those who sought medical help than in those who did not. CONCLUSIONS: People with IBS experience significant impairment in HRQOL, including both physical and mental well-being. People with IBS who seek medical help report worse physical health than those who do not, but their mental health is no different. 相似文献
2.
Kathleen Pierson Donald Addington Jean Addington Scott Patten 《Revue canadienne de psychiatrie》2006,51(11):715-718
OBJECTIVE: To assess whether pharmacokinetic drug interactions occur when sertraline is added to antipsychotic medications. METHOD: Forty-eight patients with remitted DSM-IV schizophrenia and comorbid major depression were randomized to placebo for 6 weeks or sertraline 50 mg for 4 weeks followed by sertraline 50 mg to 100 mg for 2 weeks for nonresponders. Treatment with the patients' usual antipsychotic continued. Weekly clinical outcome assessments occurred for 6 weeks, and serum samples for drug monitoring were collected at Weeks 1, 5, and 6. Serum concentrations of sertraline and antipsychotics were measured with standard assays. RESULTS: In both placebo- and sertraline-treated groups, most patients displayed minor fluctuations in antipsychotic serum levels over 6 weeks. There was no clinical evidence of drug interactions in the sertraline-treated group. CONCLUSIONS: Clinically significant adverse effects did not occur despite variable antipsychotic serum levels with or without sertraline. Concern about pharmacokinetic interactions should not deter the use of sertraline for depression in individuals with schizophrenia. 相似文献
3.
Donald E. Addington Emily McKenzie Jean Addington Scott Patten Harvey Smith Carol Adair 《Early intervention in psychiatry》2007,1(2):157-167
Aim: The purpose of this project was to operationalize and apply a previously identified set of performance measures designed to evaluate services for those experiencing a first episode of a schizophrenia spectrum disorder. Methods: Operational definitions were developed for previously identified measures through an iterative process of discussions between clinical experts and health‐care evaluators. Data were collected from existing sources including corporate databases, clinical databases and chart review. Results: Definitions were developed for 44 measures covering seven of eight domains recommended for service level evaluation by the Canadian Institute for Health Information domains. Forty measures could be calculated. Conclusions: The measures represent a comprehensive set of performance measures suitable for the evaluation of services for people with a first‐episode psychosis. The measures could be used by other services in order to establish standards and norms for routine clinical practice. 相似文献
4.
STELLA Frunza Patten M.D. Jacob W.E. Dijkstra M.D. 《International journal of dermatology》1994,33(12):836-842
5.
6.
Genotype-phenotype correlation for nucleotide substitutions in the IgII- IgIII linker of FGFR2 总被引:6,自引:3,他引:3
7.
8.
9.
Mariner DJ Sirotkin H Daniel JM Lindman BR Mernaugh RL Patten AK Thoreson MA Reynolds AB 《Hybridoma》1999,18(4):343-349
We have generated the first monoclonal antibodies (MAbs) to Armadillo repeat gene deleted in velo-cardiofacial syndrome (ARVCF), a recently identified Armadillo repeat-containing protein closely related to the catenin p120ctn. Six ARVCF-specific MAbs were characterized for isotype, species cross-reactivity, and utility in assays including immunofluorescence, immunoprecipitation, and Western blotting. All six antibodies were isotyped as IgG1 and several cross-reacted with ARVCF from a variety of species including human, rat, dog, and monkey, but not mouse. Importantly, none of the ARVCF MAbs cross-reacted with p120ctn, despite the high homology between these proteins. MAbs 3B2 and 4B1 were consistently the best in all applications and will provide valuable tools for further study of the role of ARVCF in cells. 相似文献
10.
L Ozzello CM De Rosa EW Blank K Cantell RL Ceriani DV Habif Sr 《Breast cancer research and treatment》1993,25(3):265-276
Summary An immunoconjugate composed of natural interferon (nIFN) bound in a noncleavable fashion to a monoclonal antibody (MoAb) recognizing a breast epithelial membrane mucin (Mc5) was used to treat xenografts of a human mammary carcinoma cell line (MCF-7) growing in nude mice. The immunoconjugate (nIFN/Mc5) was administered as 20 intralesional (i.l.) injections to 1 of 2 xenografts in each animal. It was found that nIFN/Mc5 produced a significant enhancement of the growth inhibitory actions of nIFN on the injected tumors. Further enhancement was obtained when nIFN or nIFN together with Mc5 (at a dose 10 times larger than that present in nIFN/Mc5) were added to the immunoconjugate. Biodistribution experiments showed that the uptake of125I-nIFN/Mc5 by the tumors was greater and its elimination slower than for125I-nIFN alone or conjugated to irrelevant mouse IgG1. In addition, the immunoconjugate up-regulated the antigenic expression of a breast epithelial membrane mucin by the carcinoma cells, an up-regulation which was not significantly different from that produced by nIFN alone. The contralateral noninjected tumors exposed to systemic levels of the immunoconjugate showed an enhancement of antitumor effects, but to a lesser extent than the injected tumors. These findings suggest that the enhancement of the growth inhibitory action of the immunoconjugate was related to the specific binding of Mc5 which targeted the IFN to the carcinoma cells and impeded its elimination. It is likely that the targeting was favored by the IFN-mediated up-regulation of antigenic expression by the carcinoma cells, thereby producing a cascade of interrelated effects. The results of this study point out the feasibility and potential usefulness of IFN treatment by means of immunoconjugates as well as the worth of pursuing and improving this form of therapy. 相似文献